BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15908786)

  • 1. Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
    Hustinx SR; Fukushima N; Zahurak ML; Riall TS; Maitra A; Brosens L; Cameron JL; Yeo CJ; Offerhaus GJ; Hruban RH; Goggins M
    Cancer Biol Ther; 2005 May; 4(5):596-601. PubMed ID: 15908786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
    Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
    Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
    Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
    Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling identifies markers of ampullary adenocarcinoma.
    Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
    Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
    Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
    Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
    Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
    BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
    Horie-Inoue K; Inoue S
    Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.
    Li Z; Dong Z; Myer D; Yip-Schneider M; Liu J; Cui P; Schmidt CM; Zhang JT
    BMC Cancer; 2010 Nov; 10():598. PubMed ID: 21040574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
    Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
    Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and diagnosing ampullary neoplasms.
    Wang LF; Hingorani SR; Tuveson DA
    Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
    [No Abstract]   [Full Text] [Related]  

  • 16. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
    Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
    J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J; Zamboni G; Longnecker D; Klöppel G
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
    Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
    Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.
    Brody JR; Witkiewicz A; Williams TK; Kadkol SS; Cozzitorto J; Durkan B; Pasternack GR; Yeo CJ
    Mod Pathol; 2007 Dec; 20(12):1238-44. PubMed ID: 17906614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.